Details for 2018739593

Up to date per 03.04.2026

Actions

Title / Product Name

VERWENDUNG VON CLADRIBIN ZUR BEHANDLUNG AUTOIMMUNER NEUROMUSKULÄRER ERKRANKUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018739593

EP Publication Number

3654989

E-Number

1646123

Language

PCT Number

GB18051801

Publication Date

27.05.2020 A

03.01.2024 B1

Registration Date

03.01.2024

AT Publication Date

15.01.2024

Application Date

28.06.2018

Registration Number

Priorities

21.07.2017

201711800

IPC

A61K 31/7076 20060101AFI20190125BHEP

Maximum Duration of Protection

28.06.2038

Owner

Chord Therapeutics SAc/o ARES TRADING SA Terre Bonne Business Park Route de Crassier 1 1262 EysinsCH

Representative

Puchberger & Partner PatentanwälteReichsratsstraße 131010 WienAT

Inventor

REJDAK, KonradOrganowa 3/20 20-882 LublinPL

Information about Fees